Johnson & Johnson

Professor Adrian Hill, chief investigator of the trials with the Ebola vaccine called Chimp Adenovirus type 3 (ChAd3), holds up a vial in September in Oxford, England. Johnson & Johnson announced they will begin testing an Ebola virus vaccine.

The economics behind the rush for an Ebola vaccine

Oct 22, 2014
Believe it or not, experts say the profit motive is secondary.
Posted In: Ebola, Ebola vaccine, Johnson & Johnson

Johnson & Johnson to pay $2.2 billion in Risperdal settlement

Nov 5, 2013
In one of the biggest cases of health care fraud ever, J&J is being fined for improperly marketing a drug for treating schizophrenia.
Posted In: Johnson & Johnson, fraud

MID-DAY UPDATE: Flight delays and electric cars

Oct 19, 2010
Flight delays don't only cost you a lot of frustration and time -- they also happen to cost the country more than $32 billion a year. Jeremy Hobson...
Posted In: Bank of America, Banks, China, electric cars, flight delays, foreclosures, France, hybrid cars, Johnson & Johnson, mid-day update